Document Detail


Acute erythroid leukemia.
MedLine Citation:
PMID:  20807044     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Acute erythroid leukemia (AEL) is an uncommon type of acute myeloid leukemia (AML), representing less than 5% of all cases. Acute erythroid leukemia is characterized by a predominant erythroid proliferation, and in the current World Health Organization (WHO) classification scheme there are 2 subtypes: erythroleukemia (erythroid/myeloid leukemia) and pure erythroid leukemia. Morphologic findings are most important for establishing the diagnosis. The erythroleukemia subtype, which is most common, is defined as the presence of 50% or more erythroid precursors and 20% or more blasts in the nonerythroid component. The pure erythroid leukemia subtype is composed of 80% or more immature erythroblasts. Although these morphologic criteria appear straightforward, AEL overlaps with other types of AML and myelodysplastic syndrome that are erythroid rich. OBJECTIVE: To provide an update of AEL, including clinical presentation, morphologic features, immunophenotype, and cytogenetic and molecular data. As the erythroleukemia subtype is most common, the literature and this review are biased towards this subtype of AEL. DATA SOURCES: Clinicopathologic, cytogenetic, and molecular information were extracted from our review of pertinent literature and a subset of AEL cases in the files of The University of Texas M. D. Anderson Cancer Center (Houston) and University of South Alabama (Mobile). CONCLUSIONS: The current WHO criteria for establishing the diagnosis of AEL reduce the frequency of this entity, as cases once classified as the erythroleukemia subtype are now reclassified as other types of AML, particularly AML with myelodysplasia-related changes and therapy-related AML. This reclassification also may have prognostic significance for patients with the erythroleukemia subtype of AEL. In contrast, the current WHO criteria appear to have little impact on the frequency and poor prognosis of patients with the pure erythroid leukemia subtype of AEL. Molecular studies, preferably using high-throughput methods, are needed for a better understanding of the pathogenesis of AEL, and for developing diagnostic and prognostic markers.
Authors:
Zhuang Zuo; Jacek M Polski; Armen Kasyan; L Jeffrey Medeiros
Related Documents :
2098294 - The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological stud...
1615924 - Acute monocytic leukemia with chloroacetate esterase positivity. fab m4 or m5?
8816294 - Reversal of cns-prophylaxis-related leukoencephalopathy after csf shunting: case histor...
11186174 - Gelatinous bone marrow transformation in a case of idiopathic myelofibrosis: a morpholo...
20201814 - The role of topiramate and other anticonvulsants in the treatment of alcohol dependence...
8528784 - Traumatic atlantooccipital dislocation with survival: case report and review of the lit...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Archives of pathology & laboratory medicine     Volume:  134     ISSN:  1543-2165     ISO Abbreviation:  Arch. Pathol. Lab. Med.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-02     Completed Date:  2010-09-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7607091     Medline TA:  Arch Pathol Lab Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1261-70     Citation Subset:  AIM; IM    
Affiliation:
Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. zzuo@mdanderson.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cytogenetic Analysis
Erythroid Cells / immunology,  pathology*
Flow Cytometry
Humans
Immunophenotyping
Leukemia, Erythroblastic, Acute / classification,  etiology,  pathology*
Mutation
Tumor Markers, Biological / analysis
World Health Organization
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new study of intraosseous blood for laboratory analysis.
Next Document:  Adenocarcinoma in ectopic prostatic tissue at dome of bladder: a case report of a patient with uroth...